Keosys

Keosys, established in 2001 and headquartered in Nantes, France, is an expert in the centralization of medical imaging for evaluating drug efficacy in international clinical trials ranging from Phase I to Phase IV. Keosys covers a wide range of imaging modalities (including echocardiography, radiography, CT, PET scans, and MRI) and therapeutic areas, with specific expertise in oncology. The company’s operations are based on its proprietary CTMS and central imaging platform, Imagys, which integrates data management/centralization tools with an image visualization system. Since 2020, the company has been led by Arthur Painvin and employs 40 people, serving as a key partner for pharmaceutical and biotechnology companies.